fbpx

Essilor Announces Latest Progressive Lens Innovation: Varilux® Physio® extensee Lens

Essilor Varilux physop extensee logo

Essilor® presents its first Varilux® lens developed using a dynamic replica of the human pupil to offer high vision intensity in any light for extra visual sharpness and contrast(1).

Powered by Varilux® lens AI twinning technology and pupil-variation predicting, the Varilux® Physio® extenseeTM lens is designed to provide optimized correction for each wearer’s pupil dynamics to reduce high-order aberrations and offer extra visual sharpness and contrast(1).

The pupil is dynamic, constantly adapts to new lighting conditions, its ability to change size and adapt to light is unique to each individual. Most progressive lenses are designed based on the wearer’s pupil size remaining constant in all lighting situations, but this can be problematic and negatively impact vision. Indeed, even the most satisfied progressive lens wearers complain about a drop in visual performance in various lighting environments:

39% are very interested in corrective lenses designed to improve their vision comfort regardless of light intensity(2).

Sébastien Fricker, Vision and Perception Modelling Team Manager at EssilorLuxottica said: “When the size of the pupil increases, the light beam entering the eye crosses a bigger portion of the lens. As a result, it can contain more high-order aberrations and induce a loss in image quality.

“Therefore, accounting for pupil-size variation in lens design is key for maximizing contrast perception and visual performance for wearers.”

Pupilizer

AI Digital Twinning + computer-lr

Only recently have vision scientists been able to derive a model which considers the main parameters that influence pupil size(3). The result is a state-of-the-art dynamic pupil model that integrates multiple studies and datasets to describe and detail pupil size variations.

Enriched for the first time by this comprehensive dynamic pupil model, Varilux® AI twinning technology replicates thousands of wearer profiles, performing multiple tasks at all distances, in different light conditions. It then analyses this powerful data to predict wearers’ pupil size variation, resulting in Pupilizer(TM) lens technology.

Thanks to pupil-variation prediction, Pupilizer(TM) lens technology is built into the Varilux® Physio® extensee(TM) lens to reduce high-order aberrations and minimise distortion when light passes the lens. By associating a prescription to a predicted pupil dynamism profile, the lens can be produced to closely match the wearer’s daily, real-life pupil variations.

Dual Booster

Dual Booster horizontal-lr

Close-up vision is one of the major pain points for progressive lens wearers, with 41% reporting have difficulty reading fine print(2). Dual BoosterTM lens surfacing technology is designed to optimize near vision. Varilux® Physio® extensee™ is a dual-sided lens, carefully engineered between the back and front surfaces to provide a magnification effect in the near vision zone ; without impacting the aesthetic of the lens or the overall progressive power.

This dual surface provides a high quality of vision at near to aid with tasks such as reading fine print.

Synchroneyes®

Synchroneyes - print-lr

The management of binocular vision in Varilux® Physio® extenseeTM lens is enhanced thanks to integrating the Synchroneyes® lens technology.

This balances the left and right lenses’ designs to match power distributions and patterns of unwanted astigmatism, and allows for a wider field of vision.

A real-life consumer study carried out by an independent institute on 79 progressive lens wearers equipped with Varilux® Physio® extensee™ lenses in their daily lives showed that:

  • 94% experienced high vision intensity in any light(1).
  • 92% felt confident in low light conditions (1).
  • 96% experienced a high quality of vision at near (4).

AI simulations were also performed using twinning technology to compare the performance of the Varilux® Physio® extenseeTM lens compared to similar lenses on the market and showed a 25% enhancement in contrast and sharpness in all light conditions, even in low light(5).

As 9/10 people have a unique near vision behaviour(6), Varilux® Physio® extensee™ lenses can now include Near Vision Behaviour measurement. It personalizes the near vision zone by adjusting its position and size.

  • 71% of wearers easily accessed the near vision zone(7)
  • 78% of wearers experienced extra comfortable vision during a long task in near vision(7)

EXPERT Q&A

Experts from EssilorLuxottica answer some questions on the new lens and how it can benefit wearers.

How does Varilux® Physio® extensee™ lens improve vision quality across various light environments?

Sébastien Fricker, Vision and Perception Modelling Team Manager at EssilorLuxottica, said: “Today there is still a pain point amongst progressive lens wearers, with our recent consumer study revealing that 39% are very interested in corrective lenses designed to improve their vision comfort regardless of light intensity.(2)

“It was therefore evident that we should continue addressing this issue and with our fourth generation of Varilux® Physio® lens, we are now able to take advantage of improved calculations and design capability to create a better lens to help manage low light conditions.

“Thanks to AI twinning technology, pupil size variations can be predicted for each wearer and during the design of this PupilizerTM lens technology we not only considered low light conditions but a whole range of environments to find the best surface to provide optimal vision at all times.”

Can you simplify how the lens works for wearers?

Sébastien Fricker said: “When the pupil is behind a progressive lens it can be prone to high-order aberrations, which are optical defects that lead to vision being less sharp. When the pupil is small in bright light these defects are negligible but the bigger the pupil gets in lower light settings, the more these high- order aberrations will have an impact on vision quality. This affects contrast sensitivity which is the ability to see differences in shades of the same colour ; and sharpness which is the ability to distinguish the fine details of an object.”

“However, during the design of Varilux® Physio® extenseeTM lens, our R&D team used the pupil-variation modelling in the digital twin, which is a virtual wearer that can simulate a real person in daily life.”

“With this extra data, AI simulations were carried out by the digital twin based on wearers of different ages, in different light environments from dim to bright light and in-between, at different distances, performing different tasks. Using all this data we were able to create PupilizerTM lens technology and modify the shape of the lens to reduce these optical defects caused by low light.”

How is the pupil model used to personalise the lens?

Sébastien Fricker said: “The pupil size is related to four parameters which have the most impact. One is age and as we grow older our pupil size decreases. The others are related to the environment including the brightness, proximity and the size of the object being viewed.”

“The data from the pupil-variation modelling is fed into our digital twin allowing us to personalise the optical lens even further. When the lab receives a patient’s prescription, they will incorporate the pupil dynamic profile as part of the lens calculation to optimise and build the lens.”

How does the latest technology meet the needs of today’s presbyopes?

Meena Puar, Global Medical Advisor – Presbyopia at EssilorLuxottica, said: “Presbyopia, a condition that impairs near vision, tends to worsen over time, with the challenges increasing as the severity of the

condition progresses. These near vision tasks are typically more challenging if the lighting is not optimal, which can affect contrast and sharpness. In modern day scenarios, today’s presbyopes are seeking high quality vision across all lighting environments throughout the day.

“To prescribe the latest lens technologies is an opportunity to address the evolving needs of presbyopic patients. The Varilux® Physio® extensee™ lens is designed to cater to a wide range of presbyopes. It incorporates an innovative dynamic pupil model, which takes the pupil size into account in different lighting conditions and across various distances.”

References

  1. Varilux® Physio® extensee™ – in-real life consumer study – Eurosyn – 2024 – France (n=79 progressive lens wearers)
  2. Essilor International – Vision Care Usage and Attitudes – CN/FR/US – June Marketing – 2023 (n=10 611 respondents). • 39% : Analysis based on 481 (45-65 yo PAL wearers) • 41% : Analysis based on 1 350 (45-65 yo PAL wearers)
  3. Zapata-Díaz, Juan F., Hema Radhakrishnan, W. Neil Charman, and Norberto López-Gil. (2019). Accommodation and Age-Dependent Eye Model Based on in Vivo Measurements. Journal of Optometry, 12(no. 1), 3–13.
  4. Varilux® Physio® extensee™ – in-real life consumer study – Eurosyn – 2024 – France (n=60 progressive lens wearers)
  5. Simulations vs relevant progressive lens products – done with AI twinning technology during activities in near vision in various luminance – Comparison between mean’s value based on several prescriptions & materials – Internal R&D simulations – 2024
  6. EssilorLuxottica R&D analysis of near vision behavior data from 160k orders, at least one parameter out of four of visual behavior differs from the average
  7. Varilux® Physio® extensee™ track – in-real life consumer study – Eurosyn – 2024 – France (n=57 progressive lens wearers).
  8. Euromonitor, Eyewear 2023 edition; Essilor International company; worldwide retail value sales at RSP.
  9. Quantitative research conducted among a representative sample of 958 independent ECPs by CSA in February 2019 – France, the UK, Germany, Italy, Spain, the US, Canada, Brazil, China, India.

Click HERE for the press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

MiSight® Spectacle Lenses Powered by Diffusion Optics Technology™ Launches in Canada to Slow Myopia Progression

CooperVision

CooperVision announced the launch of breakthrough MiSight® Spectacle Lenses powered by Diffusion Optics Technologyfor myopia control in Canada. 

Diffusion Optics Technology™ uses a unique, patent-protected mechanism to lower contrast signals that can cause myopia progression in children.1 Beginning July 1st, Canadian Eye Care Professionals will be able to prescribe this proven intervention to help slow the progression of myopia in their young patients.±2

The innovative approach is backed by extensive research, including the pivotal CYPRESS clinical trial conducted across 14 sites in North America1 and the ongoing CATHAY clinical trial across 5 sites in China.3 MiSight® Spectacle Lenses slow average myopia progression by up to 75% after 12 months of wear across diverse populations of children.‡1,3

The rigorous, multi-site four-year CYPRESS clinical trial demonstrated that among children wearing MiSight® Spectacle Lenses, 41% of children showed no meaningful progression in refractive error over 24 months.†2 

“MiSight® Spectacle Lenses provide another scientifically proven myopia control option alongside our MiSight® 1 day.* We are enthusiastic about bringing this advancement to Eye Care Professionals in Canada, and about the potential it offers for so many children,” said Enrique Contreras, Country Manager for CooperVision Canada.

“We expect the availability of MiSight® Spectacle Lenses to significantly expand myopia control access4 for children in Canada, particularly among younger patients for whom spectacles may be a preferred form of treatment. Adding MiSight® Spectacle Lenses to an Eye Care Professional’s toolbox helps to increase access to evidence-based technologies, especially for younger children, which helps drive towards a shared goal of making myopia management a standard of care,” said Andrew Sedgwick, CEO of SightGlass Vision.

MiSight® Spectacle Lenses provide a positive wearing experience with 93% of children saying they love their MiSight® Spectacle Lenses.│2 Studies also show that MiSight® Spectacle Lenses provide a clinically equivalent visual experience to standard single vision lenses.5-7

For more information, visit CooperVision.ca and SightGlassVision.com.

_______________________________________

* USA Indication: MiSight® 1 Day (omafilcon A) Soft (Hydrophilic) Contact Lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal. Canadian Indications for Use: MiSight (omafilcon A) Soft Contact Lenses for Myopia Control may reduce the rate of myopia progression in children (6-18) and correct ametropia. Reduction of myopia progression was observed in children with wearing time of 12 hours (8-16 hours) per day, 6.4 days (5-7) per week in a clinical study. Permanent myopia control after lens treatment is discontinued is not supported by clinical studies. MiSight (omafilcon A) Soft Contact Lenses for Myopia Control are indicated for single-use daily disposable wear. When prescribed for daily disposable wear, the lens is to be discarded after each removal.

± Reduction in progression of spherical equivalent refraction and axial length from baseline over 24 months was 47% and 24% on average, respectively (p<0.0041).

‡ Based on a North American patient population aged 6–10 years (least-squared means) and a Chinese patient population aged 6–13 years (unadjusted means). Significant progression is defined as >0.25 D change from baseline.

† No clinically meaningful change in refractive error means that there was less than a 0.25D increase in myopia from baseline as measured by cycloplegic autorefraction. (p<0.0001). 

│Proportion agreeing to “I love my DOT glasses” at the 30-day visit.

References

1 Rappon et al. Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomized controlled, efficacy and safety study (CYPRESS). Br J Opthalmol. 2023 Nov; 107(11): 1709:1715. 

2 SGV data on file 2021. Control of Myopia Using Peripheral Diffusion Lenses: Efficacy and Safety Study, 24-month results (n = 256, 14 North American sites).

3 Laughton D., et al. Control of myopia using diffusion optics spectacle lenses in a Chinese population: 12-month results. 2025 ARVO poster presentation. 24-month, randomized and controlled clinical trial across 5 Chinese hospital sites, evaluating DOT spectacle lenses (n=128) versus control standard single vision spectacle lenses (n=58) in myopic children aged 6–13. 

4 Rappon et al. Two-year effectiveness of a novel myopia management spectacle lens in full-time wearers. Invest. Ophthalmol. Vis. Sci. 2022;63(7):408.

5 SGV data on file 2022. Control of Myopia Using Peripheral Diffusion Lenses: Efficacy and Safety Study, 3-Year Report (n = 256, 14 North American sites).

6 Laughton D et al. Safety and efficacy of a novel spectacle lens for myopia control over three years. AAOptom conference 2022 presentation.

7 Wolffsohn JS, Hill JS, Laughton D, Hunt C, Young G. Visual Impact of Diffusion Optics Technology Lenses for Myopia Control. AAOptom conference poster presentation 2023.

Click HERE for the press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

LE PARC – Timeless Lines, a Bold Perspective

Optik Voila May-June 2025 Mood Le PArc Marcellis

From the Spring/Summer 2025 collection and “Dots” campaign, Marcelis isa sophisticated combination of acetate textures and timeless lines. Inspiredby Op Art and founder Miquel Dosta’s artistic roots, this frame captures LEPARC’s bold spirit—merging creative heritage with playful design in a refined,expressive, and accessible eyewear statement.

Distributed by Mood Eyewear: www.moodeyewear.com

About Mood Eyewear:

Mood Eyewear Inc is proud to lead in the latest European optical trends, integrating European fashion influences to enhance the visual experience. We consider it both a duty and an honor to support our business partners by providing personalized and efficient service. Our exclusive collections are carefully curated to blend creativity, innovation, art, design, craftsmanship, and cutting-edge technology.

Established in 2006, Mood Eyewear was founded with the aim of importing and offering prestigious optical and sunglass collections to the Canadian market. Our group ensures the distribution of renowned European brands, selected for their quality and distinctive aesthetics. 

We are the exclusive distributors in Canada for brands such as Blackfin, Woodys, Le Parc, Visionario, X-Ide, MIC, I-Man, Komono, and Kunoquist.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e- newsletters!

Safilo, Victoria Beckham Announce Ten-Year Global Licensing Agreement for Eyewear Collections

Safilo Group Victoria Beckham logos July 2025

Safilo Group and Victoria Beckham, Creative Director and Founder of her eponymous brand, announce their new ten-year global licensing agreement for the design, manufacturing and distribution of the Victoria Beckham branded eyewear collections until December 2035.

The full eyewear range – both optical and sun – will be unveiled for the Spring-Summer 2026 season, hitting the market in January 2026.

“We are excited to welcome to our portfolio one of the industry’s most iconic creative directors. Together, we aim to strengthen the brand’s position as a global eyewear reference in women’s fashion, offering uniquely designed and beautifully crafted pieces that stand out for their attention to detail, minimal design, and sophisticated aesthetics – a luxury proposition empowered by the influence and legacy of Victoria Beckham, who has successfully built and affirmed her brand within the fashion industry” – declared Angelo Trocchia, CEO of Safilo Group. “This collaboration will further enhance the women’s portfolio within Safilo’s brand architecture and strengthen our presence in the luxury segment”.

“I’m thrilled to be working with Safilo to take Victoria Beckham Eyewear to the next level. Their expertise in the field is unparalleled, with a long-standing reputation for exceptional quality and craftsmanship. With their global reach and industry-leading capabilities, I’m excited about the opportunities ahead and can’t wait to bring our shared vision to life,” said Victoria Beckham, the brand’s Creative Director.

Click HERE for the press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

AIPL1 Gene Therapy Restores vision in small clinical trial

Fighting Blindness Canada research

Four children with Leber congenital amaurosis 4 (LCA4) have experienced meaningful improvements in their vision after receiving a gene therapy treatment.

The treatment was a gene replacement therapy for individuals with mutations in the AIPL1 gene, which leads to blindness from birth. The new treatment delivers healthy copies of the gene into the retina, helping retinal cells survive and work more effectively.

The treatment was developed by UCL Institute of Ophthalmology and Moorfields Eye Hospital, with support from MeiraGTx. To ensure safety, only one eye was treated. Over the next three to four years, vision in the treated eye improved significantly, while vision in untreated eye continued to decline.

The results of this study were published in The Lancet and highlight the potential of early gene therapy to restore sight in children with severe vision loss caused by and inherited retinal disease.

Researchers are now working to make this treatment more widely available.

About Fighting Blindness Canada

Fighting Blindness Canada (FBC) is the largest charitable funder of vision research in Canada.

Over our 49-year history, FBC has contributed critical funding for the development of sight-saving treatments and cures for blinding eye diseases. By raising and stewarding funds, FBC is helping drive forward research that supports our goal of understanding why vision loss occurs, how it can be slowed and how sight can be restored.

We are an invaluable resource for individuals and families impacted by blindness, providing accurate eye health information through our website and educational events, as well as engaging with government and other stakeholders to advance better vision health policies.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e- newsletters!

Featured Posts

Vision Expo new logo

Vision Expo 2026 Launches “Call for NEW” to Spotlight Industry Innovation

Vision Expo 2026 launches its Call for NEW initiative, spotlighting product debuts, technologies and innovations ahead of the unified annual event in Orlando.

Learn More
EssilorLuxottica

EssilorLuxottica Joins Forces with Fondazione Chips-IT to Accelerate the Future of Smart Eyewear

EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate smart-eyewear innovation through next-generation chip design, open-hardware collaboration and advanced wearable technologies.

Read more
JF Rey Collection Femme Dec 2025

J.F. Rey Unveils New Women’s Collection Showcasing Exceptional Craftsmanship and Mastery of Colour

J.F. Rey launches its new Women’s Collection with 11 shapes and 55 colours, showcasing exceptional craftsmanship, bold design and masterful colour innovation.

Read more
Opti Munich 2026 logo

opti 2026 Unveils TOMORROW VISION and opti SPHEARE: New Platforms for Contact Lens Innovation and Hearing Care

opti 2026 is spotlighting two major growth drivers: TOMORROW VISION, a high-energy innovation platform for contact lenses, and opti SPHEARE, a new experiential centre for hearing care.

Read more
Essilor Stellest 2.0 lenses

EssilorLuxottica Introduces Essilor® Stellest® 2.0 Lenses to Canada, Advancing Childhood Myopia Management

EssilorLuxottica has introduced Essilor® Stellest® 2.0 lenses in Canada, offering stronger efficacy and enhanced design features for childhood myopia management.

Read more
Vision Expo new logo

Vision Expo 2026 Launches “Call for NEW” to Spotlight Industry Innovation

Vision Expo 2026 launches its Call for NEW initiative, spotlighting product debuts, technologies and innovations ahead of the unified annual event in Orlando.

Learn More
EssilorLuxottica

EssilorLuxottica Joins Forces with Fondazione Chips-IT to Accelerate the Future of Smart Eyewear

EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate smart-eyewear innovation through next-generation chip design, open-hardware collaboration and advanced wearable technologies.

Read More
JF Rey Collection Femme Dec 2025

J.F. Rey Unveils New Women’s Collection Showcasing Exceptional Craftsmanship and Mastery of Colour

J.F. Rey launches its new Women’s Collection with 11 shapes and 55 colours, showcasing exceptional craftsmanship, bold design and masterful colour innovation.

Read More
Opti Munich 2026 logo

opti 2026 Unveils TOMORROW VISION and opti SPHEARE: New Platforms for Contact Lens Innovation and Hearing Care

opti 2026 is spotlighting two major growth drivers: TOMORROW VISION, a high-energy innovation platform for contact lenses, and opti SPHEARE, a new experiential centre for hearing care.

Read More
Essilor Stellest 2.0 lenses

EssilorLuxottica Introduces Essilor® Stellest® 2.0 Lenses to Canada, Advancing Childhood Myopia Management

EssilorLuxottica has introduced Essilor® Stellest® 2.0 lenses in Canada, offering stronger efficacy and enhanced design features for childhood myopia management.

Read More
Vision Expo new logo

Vision Expo 2026 Launches “Call for NEW” to Spotlight Industry Innovation

Vision Expo 2026 launches its Call for NEW initiative, spotlighting product debuts, technologies and innovations ahead of the unified annual event in Orlando.

Learn More
EssilorLuxottica

EssilorLuxottica Joins Forces with Fondazione Chips-IT to Accelerate the Future of Smart Eyewear

EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate smart-eyewear innovation through next-generation chip design, open-hardware collaboration and advanced wearable technologies.

Read more
JF Rey Collection Femme Dec 2025

J.F. Rey Unveils New Women’s Collection Showcasing Exceptional Craftsmanship and Mastery of Colour

J.F. Rey launches its new Women’s Collection with 11 shapes and 55 colours, showcasing exceptional craftsmanship, bold design and masterful colour innovation.

Read more
Opti Munich 2026 logo

opti 2026 Unveils TOMORROW VISION and opti SPHEARE: New Platforms for Contact Lens Innovation and Hearing Care

opti 2026 is spotlighting two major growth drivers: TOMORROW VISION, a high-energy innovation platform for contact lenses, and opti SPHEARE, a new experiential centre for hearing care.

Read more
Essilor Stellest 2.0 lenses

EssilorLuxottica Introduces Essilor® Stellest® 2.0 Lenses to Canada, Advancing Childhood Myopia Management

EssilorLuxottica has introduced Essilor® Stellest® 2.0 lenses in Canada, offering stronger efficacy and enhanced design features for childhood myopia management.

Read more
Vision Expo new logo

Vision Expo 2026 Launches “Call for NEW” to Spotlight Industry Innovation

Vision Expo 2026 launches its Call for NEW initiative, spotlighting product debuts, technologies and innovations ahead of the unified annual event in Orlando.

Learn More
EssilorLuxottica

EssilorLuxottica Joins Forces with Fondazione Chips-IT to Accelerate the Future of Smart Eyewear

EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate smart-eyewear innovation through next-generation chip design, open-hardware collaboration and advanced wearable technologies.

Read more
JF Rey Collection Femme Dec 2025

J.F. Rey Unveils New Women’s Collection Showcasing Exceptional Craftsmanship and Mastery of Colour

J.F. Rey launches its new Women’s Collection with 11 shapes and 55 colours, showcasing exceptional craftsmanship, bold design and masterful colour innovation.

Read more
Opti Munich 2026 logo

opti 2026 Unveils TOMORROW VISION and opti SPHEARE: New Platforms for Contact Lens Innovation and Hearing Care

opti 2026 is spotlighting two major growth drivers: TOMORROW VISION, a high-energy innovation platform for contact lenses, and opti SPHEARE, a new experiential centre for hearing care.

Read more
Essilor Stellest 2.0 lenses

EssilorLuxottica Introduces Essilor® Stellest® 2.0 Lenses to Canada, Advancing Childhood Myopia Management

EssilorLuxottica has introduced Essilor® Stellest® 2.0 lenses in Canada, offering stronger efficacy and enhanced design features for childhood myopia management.

Read more